Oncology | Optimizing the Use of Targeted Therapies in First and Subsequent Lines of Treatment for ALK-Positive Non-Small Cell Lung Cancer
Although non-small cell lung cancer (NSCLC) is a lung cancer subtype that comprises up to 90% of patients diagnosed with cancer, it continues to be a leading cause of cancer death. However, several targeted therapies that were recently approved and those in late-stage development have given renewed hope for increased survival of patients diagnosed with anaplastic lymphoma kinase-positive (ALK+) NSCLC. This activity addresses the intricate paradigm of treating patients diagnosed with ALK+ NSCLC.
- Accreditation Statement: The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
- Statement of Contact Hours: This educational activity is provided by The Institute for Johns Hopkins Nursing. The contact hours will be awarded from the Oncology Consults website after the completion.
- Conflict of Interest: It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program. The planning committee and program faculty report that they do not have financial relationships with manufacturers of any commercial products they discuss in the program.
- Commercial Support: This educational activity has not received any form of commercial support.
- Non-Endorsement of Products: The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
- 0.50 ANCC
You will be redirected to the myCME website.
If you do not have an account on their website you will need to create an account before logging in to access this free course.
Click HERE to be directed to the article and proceed as instructed on the site. A certificate of participation will be available online immediately following successful completion of the activity.